Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Birich Technologies

Out of Business LATEST DEAL TYPE

Developer of gene-silencing technology designed to detect diseases. The company's gene-silencing technology offers a proprietary protein delivery technology for RNAI, enabling doctors to detect and treat gene related diseases.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 301 West Preston Street
  • Room 801
  • Baltimore, MD 21201
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Birich Technologies’s full profile, request a free trial.

Birich Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2016 00000 Completed Out of Business
2. Seed Round 26-Feb-2014 00000 00000 Completed Startup
1. Accelerator/Incubator 20-Feb-2013 $149K $149K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Birich Technologies Executive Team (3)

Name Title Board
Vivek Advani Acting Chief Technology Officer
Kevin Diehn Co-Founder & Chief Executive Officer
Chanda Arya Ph.D Co-Founder & President